Protalix Biotherapeutics Inc (PLX)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-10-20 | 2023-10-19 | B Purchase |
PRESIDENT AND CEO Executive Director |
16,129
+13.9%
1.41USD 22,742 |
16,129 +13.9% | 1.41 | USD 22,742 | |
| 2023-10-20 | 2023-10-19 | B Purchase |
PRESIDENT AND CEO Executive Director |
48,387
+71.2%
1.40USD 67,742 |
48,387 +71.2% | 1.40 | USD 67,742 | |
| 2023-01-05 | 2023-01-03 | B Purchase | Non-Executive Director |
110,000
+171.9%
1.42USD 155,815 |
110,000 +171.9% | 1.42 | USD 155,815 | |
| 2022-04-13 | 2022-04-11 | B Purchase |
President and CEO Executive Director |
68,000
+inf%
1.50USD 102,000 |
68,000 +inf% | 1.50 | USD 102,000 | |
| 2021-06-03 | 2021-06-03 | S Sale |
Dexcel Pharma Technologies Ltd. Large shareholder |
857,506
-19.1%
2.25USD 1,932,304 |
857,506 -19.1% | 2.25 | USD 1,932,304 | |
| 2021-06-03 | 2021-06-02 | S Sale |
Dexcel Pharma Technologies Ltd. Large shareholder |
61,211
-1.3%
2.56USD 156,553 |
61,211 -1.3% | 2.56 | USD 156,553 | |
| 2020-04-13 | 2020-04-07 | B Purchase | Non-Executive Director |
64,000
+inf%
2.43USD 155,264 |
64,000 +inf% | 2.43 | USD 155,264 | |
| 2017-05-16 | 2017-05-16 | B Purchase |
Manor Moshe President & CEO Executive Director |
50,000
+inf%
0.81USD 40,500 |
50,000 +inf% | 0.81 | USD 40,500 | |
| 2016-12-06 | 2016-12-02 | S Sale |
Camber Capital Management LLC Large shareholder |
2,500,000
-18.8%
0.32USD 792,000 |
2,500,000 -18.8% | 0.32 | USD 792,000 | |
| 2015-12-15 | 2015-12-14 | B Purchase |
Maimon Yossi Vice President & CFO Officer |
10,000
+inf%
0.78USD 7,800 |
10,000 +inf% | 0.78 | USD 7,800 | |
| 2015-10-20 | 2015-10-19 | B Purchase |
Camber Capital Management LLC Large shareholder |
423
+0.0%
1.03USD 436 |
423 +0.0% | 1.03 | USD 436 | |
| 2015-10-20 | 2015-10-19 | B Purchase |
Camber Capital Management LLC Large shareholder |
4,000,000
+43.1%
1.00USD 4,000,000 |
4,000,000 +43.1% | 1.00 | USD 4,000,000 | |
| 2014-08-15 | 2014-08-13 | S Sale |
Bio-Cell Ltd Large shareholder |
4,400,000
-30.4%
2.47USD 10,868,000 |
4,400,000 -30.4% | 2.47 | USD 10,868,000 | |
| 2014-08-15 | 2014-08-13 | S Sale |
Bronfeld Zeev Non-Executive Director Large shareholder |
4,400,000
-30.4%
2.47USD 10,868,000 |
4,400,000 -30.4% | 2.47 | USD 10,868,000 | |
| 2013-08-16 | 2013-08-15 | S Sale |
Akirov Alfred Non-Executive Director |
2,330
-0.0%
5.07USD 11,813 |
2,330 -0.0% | 5.07 | USD 11,813 | |
| 2013-08-16 | 2013-08-14 | S Sale |
Akirov Alfred Non-Executive Director |
5,000
-0.1%
5.08USD 25,400 |
5,000 -0.1% | 5.08 | USD 25,400 | |
| 2013-08-16 | 2013-08-14 | S Sale |
Akirov Alfred Non-Executive Director |
5,000
-0.1%
5.07USD 25,350 |
5,000 -0.1% | 5.07 | USD 25,350 | |
| 2013-08-16 | 2013-08-14 | S Sale |
Akirov Alfred Non-Executive Director |
100,000
-2.0%
5.05USD 505,000 |
100,000 -2.0% | 5.05 | USD 505,000 | |
| 2013-03-14 | 2013-03-12 | S Sale |
Akirov Alfred Non-Executive Director |
10,000
-0.2%
5.70USD 57,000 |
10,000 -0.2% | 5.70 | USD 57,000 | |
| 2013-03-12 | 2013-03-11 | S Sale |
Akirov Alfred Non-Executive Director |
5,000
-0.1%
5.71USD 28,550 |
5,000 -0.1% | 5.71 | USD 28,550 | |
| 2013-03-12 | 2013-03-11 | S Sale |
Akirov Alfred Non-Executive Director |
10,000
-0.2%
5.72USD 57,200 |
10,000 -0.2% | 5.72 | USD 57,200 | |
| 2013-03-12 | 2013-03-11 | S Sale |
Akirov Alfred Non-Executive Director |
3,000
-0.1%
5.75USD 17,250 |
3,000 -0.1% | 5.75 | USD 17,250 | |
| 2013-03-12 | 2013-03-11 | S Sale |
Akirov Alfred Non-Executive Director |
300
-0.0%
5.79USD 1,737 |
300 -0.0% | 5.79 | USD 1,737 | |
| 2013-03-12 | 2013-03-08 | S Sale |
Akirov Alfred Non-Executive Director |
1,898
-0.0%
5.95USD 11,293 |
1,898 -0.0% | 5.95 | USD 11,293 | |
| 2013-03-12 | 2013-03-08 | S Sale |
Akirov Alfred Non-Executive Director |
2,500
-0.0%
5.92USD 14,800 |
2,500 -0.0% | 5.92 | USD 14,800 | |
| 2013-03-12 | 2013-03-08 | S Sale |
Akirov Alfred Non-Executive Director |
2,500
-0.0%
5.91USD 14,775 |
2,500 -0.0% | 5.91 | USD 14,775 | |
| 2013-03-12 | 2013-03-08 | S Sale |
Akirov Alfred Non-Executive Director |
10,000
-0.2%
5.82USD 58,200 |
10,000 -0.2% | 5.82 | USD 58,200 | |
| 2013-03-08 | 2013-03-07 | S Sale |
Akirov Alfred Non-Executive Director |
3,435
-0.1%
5.73USD 19,683 |
3,435 -0.1% | 5.73 | USD 19,683 | |
| 2013-03-08 | 2013-03-07 | S Sale |
Akirov Alfred Non-Executive Director |
5,000
-0.1%
5.71USD 28,550 |
5,000 -0.1% | 5.71 | USD 28,550 | |
| 2013-03-08 | 2013-03-06 | S Sale |
Akirov Alfred Non-Executive Director |
700
-0.0%
5.71USD 3,997 |
700 -0.0% | 5.71 | USD 3,997 | |
| 2013-03-08 | 2013-03-06 | S Sale |
Akirov Alfred Non-Executive Director |
2,000
-0.0%
5.69USD 11,380 |
2,000 -0.0% | 5.69 | USD 11,380 | |
| 2013-03-08 | 2013-03-06 | S Sale |
Akirov Alfred Non-Executive Director |
2,000
-0.0%
5.68USD 11,360 |
2,000 -0.0% | 5.68 | USD 11,360 | |
| 2012-05-04 | 2012-05-02 | PS Planned sale |
Almon Einat Brill SVP, Product Development Officer |
166,848
-100.0%
7.13USD 1,189,626 |
166,848 -100.0% | 7.13 | USD 1,189,626 | |
| 2012-05-04 | 2012-05-02 | PS Planned sale |
Aviezer David President & CEO Executive Director |
450,000
-100.0%
7.13USD 3,208,500 |
450,000 -100.0% | 7.13 | USD 3,208,500 | |
| 2012-05-04 | 2012-05-02 | PS Planned sale |
Maimon Yossi VP, Chief Financial Officer Officer |
125,964
-100.0%
7.13USD 898,123 |
125,964 -100.0% | 7.13 | USD 898,123 | |
| 2010-10-06 | 2010-10-06 | PS Planned sale |
Almon Einat Brill VP, Product Development Officer |
15,000
-100.0%
9.29USD 139,350 |
15,000 -100.0% | 9.29 | USD 139,350 | |
| 2010-10-06 | 2010-10-05 | PS Planned sale |
Almon Einat Brill VP, Product Development Officer |
20,000
-100.0%
9.08USD 181,600 |
20,000 -100.0% | 9.08 | USD 181,600 | |
| 2010-09-08 | 2010-09-07 | PS Planned sale |
Maimon Yossi VP, Chief Financial Officer Officer |
31,500
-100.0%
8.16USD 257,040 |
31,500 -100.0% | 8.16 | USD 257,040 | |
| 2010-09-08 | 2010-09-07 | PS Planned sale |
Almon Einat Brill VP, Product Development Officer |
22,500
-100.0%
8.16USD 183,600 |
22,500 -100.0% | 8.16 | USD 183,600 | |
| 2010-08-09 | 2010-08-06 | PS Planned sale |
Shaaltiel Yoseph Executive VP, R&D Executive Director |
4,619
-0.6%
7.00USD 32,333 |
4,619 -0.6% | 7.00 | USD 32,333 | |
| 2010-03-25 | 2010-03-25 | PS Planned sale |
Shaaltiel Yoseph Executive VP, R&D Executive Director |
50,000
-5.4%
7.00USD 350,000 |
50,000 -5.4% | 7.00 | USD 350,000 | |
| 2010-03-25 | 2010-03-24 | PS Planned sale |
Shaaltiel Yoseph Executive VP, R&D Executive Director |
202,700
-17.8%
7.08USD 1,435,116 |
202,700 -17.8% | 7.08 | USD 1,435,116 | |
| 2009-12-09 | 2009-12-02 | B Purchase |
Bar-Shalev Amos Non-Executive Director |
680
+68.0%
8.20USD 5,576 |
680 +68.0% | 8.20 | USD 5,576 | |
| 2009-12-09 | 2009-12-02 | B Purchase |
Bar-Shalev Amos Non-Executive Director |
1,000
+inf%
8.68USD 8,680 |
1,000 +inf% | 8.68 | USD 8,680 | |
| 2009-11-13 | 2009-11-12 | S Sale |
Hurvitz Eli Non-Executive Director |
250,000
-14.2%
10.76USD 2,690,000 |
250,000 -14.2% | 10.76 | USD 2,690,000 | |
| 2009-11-13 | 2009-11-12 | S Sale |
Hurvitz Eli Non-Executive Director |
1,121,967
-38.9%
10.00USD 11,219,670 |
1,121,967 -38.9% | 10.00 | USD 11,219,670 | |
| 2009-10-21 | 2009-10-21 | PS Planned sale |
Aviezer David CEO and President Executive Director |
34,238
-100.0%
9.36USD 320,468 |
34,238 -100.0% | 9.36 | USD 320,468 | |
| 2009-10-21 | 2009-10-20 | PS Planned sale |
Aviezer David CEO and President Executive Director |
60,000
-100.0%
9.45USD 567,000 |
60,000 -100.0% | 9.45 | USD 567,000 | |
| 2009-10-19 | 2009-10-19 | PS Planned sale |
Almon Einat Brill VP, Product Development Officer |
38,320
-100.0%
9.43USD 361,358 |
38,320 -100.0% | 9.43 | USD 361,358 | |
| 2009-10-19 | 2009-10-19 | PS Planned sale |
Shaaltiel Yoseph Executive VP, R&D Executive Director |
43,120
-3.3%
9.43USD 406,622 |
43,120 -3.3% | 9.43 | USD 406,622 | |
| 2009-10-19 | 2009-10-16 | PS Planned sale |
Almon Einat Brill VP, Product Development Officer |
23,680
-100.0%
9.39USD 222,355 |
23,680 -100.0% | 9.39 | USD 222,355 | |
| 2009-10-19 | 2009-10-16 | PS Planned sale |
Maimon Yossi VP, Chief Financial Officer Officer |
40,300
-100.0%
9.35USD 376,805 |
40,300 -100.0% | 9.35 | USD 376,805 | |
| 2009-10-19 | 2009-10-16 | PS Planned sale |
Shaaltiel Yoseph Executive VP, R&D Executive Director |
25,680
-1.9%
9.39USD 241,135 |
25,680 -1.9% | 9.39 | USD 241,135 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
974
-0.0%
7.55USD 7,354 |
974 -0.0% | 7.55 | USD 7,354 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
2,300
-0.0%
7.54USD 17,342 |
2,300 -0.0% | 7.54 | USD 17,342 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
1,700
-0.0%
7.53USD 12,801 |
1,700 -0.0% | 7.53 | USD 12,801 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
1,100
-0.0%
7.52USD 8,272 |
1,100 -0.0% | 7.52 | USD 8,272 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
750
-0.0%
7.51USD 5,633 |
750 -0.0% | 7.51 | USD 5,633 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
12,300
-0.2%
7.50USD 92,250 |
12,300 -0.2% | 7.50 | USD 92,250 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
3,716
-0.0%
7.48USD 27,796 |
3,716 -0.0% | 7.48 | USD 27,796 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
3,200
-0.0%
7.47USD 23,904 |
3,200 -0.0% | 7.47 | USD 23,904 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
1,800
-0.0%
7.45USD 13,410 |
1,800 -0.0% | 7.45 | USD 13,410 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
50,900
-0.7%
7.44USD 378,696 |
50,900 -0.7% | 7.44 | USD 378,696 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
5,596
-0.1%
7.43USD 41,578 |
5,596 -0.1% | 7.43 | USD 41,578 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
1,400
-0.0%
7.42USD 10,388 |
1,400 -0.0% | 7.42 | USD 10,388 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
8,284
-0.1%
7.41USD 61,384 |
8,284 -0.1% | 7.41 | USD 61,384 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
13,200
-0.2%
7.40USD 97,680 |
13,200 -0.2% | 7.40 | USD 97,680 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
1,600
-0.0%
7.39USD 11,824 |
1,600 -0.0% | 7.39 | USD 11,824 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
9,254
-0.1%
7.38USD 68,295 |
9,254 -0.1% | 7.38 | USD 68,295 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
4,179
-0.1%
7.37USD 30,799 |
4,179 -0.1% | 7.37 | USD 30,799 | |
| 2009-09-11 | 2009-09-10 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
5,821
-0.1%
7.35USD 42,784 |
5,821 -0.1% | 7.35 | USD 42,784 | |
| 2009-09-11 | 2009-09-09 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
1,216
-0.0%
7.62USD 9,266 |
1,216 -0.0% | 7.62 | USD 9,266 | |
| 2009-09-11 | 2009-09-09 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
6,918
-0.1%
7.61USD 52,646 |
6,918 -0.1% | 7.61 | USD 52,646 | |
| 2009-09-11 | 2009-09-09 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
912
-0.0%
7.60USD 6,931 |
912 -0.0% | 7.60 | USD 6,931 | |
| 2009-09-11 | 2009-09-09 | S Sale |
FROST PHILLIP MD ET AL Large shareholder |
300
-0.0%
7.59USD 2,277 |
300 -0.0% | 7.59 | USD 2,277 |